Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer

MLA

Mark Sausen, et al. “Circulating Tumor DNA (CtDNA) as a Prognostic Marker for Recurrence in Resected Pancreas Cancer.” Journal of Clinical Oncology, vol. 33, May 2015, p. 11025. EBSCOhost, https://doi.org/10.1200/jco.2015.33.15_suppl.11025.

APA

Mark Sausen, Elizabeth A. Sugar, Bjarne Bartlett, Ralph H. Hruban, Cherie Blair, Sara Solt-Linville, Derek Murphy, Laura D. Wood, Victor E. Velculescu, Sonya Parpart-Li, Judy Sing-Zan Wang, Elizabeth M. Jaffee, Daniel A. Laheru, Tianna Dauses, & Luis A. Diaz. (2015). Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer. Journal of Clinical Oncology, 33, 11025. https://doi.org/10.1200/jco.2015.33.15_suppl.11025

Chicago

Mark Sausen, Elizabeth A. Sugar, Bjarne Bartlett, Ralph H. Hruban, Cherie Blair, Sara Solt-Linville, Derek Murphy, et al. 2015. “Circulating Tumor DNA (CtDNA) as a Prognostic Marker for Recurrence in Resected Pancreas Cancer.” Journal of Clinical Oncology 33 (May): 11025. doi:10.1200/jco.2015.33.15_suppl.11025.